RE:RE:RE:RE:RE:SilenceI hear your frustration,
We are still waiting for reviewed data from their completed 2021 P2 trial which usually takes 6 from what I heard on another market platform. The last update we recieved from Management regarding the P2 trial was August 2021. Unless there is other material updates we are not aware of? We are almost into 2023 and still ghosted. Is this still being reviewed? was the data positive?
Insiders have bought more earlier this year and smaller amounts in spring/fall, which is a good sign regarding the company status IMO.
And great question, their cash won't last forever, when do they plan on another raise? What is their plan?